Ii Robert C. Goeltz
Chief Financial Officer · Arcus Biosciences, Inc.
- 2024
- May 12, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ii Robert C. Goeltz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Juan C. Jaen - $8.07M in RCUS purchases and sales in the last 12 months
- Jennifer Jarrett - $954K in RCUS purchases and sales in the last 12 months
- Alexander Azoy - $200K in RCUS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ii Robert C. Goeltz?
Ii Robert C. Goeltz is a corporate insider, tracked as Chief Financial Officer of Arcus Biosciences, Inc. (RCUS). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Ii Robert C. Goeltz last file a Form 4?
The most recent primary Form 4 on record is dated 12 May 2026, one of 6 filings going back to 2024.
Has Ii Robert C. Goeltz been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($577K) across all tracked filings.